The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic profiling of large-cell neuroendocrine carcinoma of the lung.
 
Tomohiro Miyoshi
Research Funding - Konica Minolta (Inst)
 
Shigeki Umemura
Honoraria - Boehringer Ingelheim
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); MSD (Inst)
 
Yuki Matsumura
No Relationships to Disclose
 
Sachiyo Mimaki
No Relationships to Disclose
 
Satoshi Tada
No Relationships to Disclose
 
Genichiro Ishii
No Relationships to Disclose
 
Shingo Matsumoto
Honoraria - Chugai Pharma; Lilly
Research Funding - Chugai Pharma (Inst); Lilly (Inst); Novartis (Inst); Oxford Oncology (Inst); Pfizer (Inst)
 
Kiyotaka Yoh
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Chugai Pharma; Lilly; Pfizer; Sanofi; Taiho Pharmaceutical
Research Funding - AstraZeneca; Lilly; Novartis; Takeda
 
Seiji Niho
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Hisamitsu Pharmaceutical; Lilly; Pfizer; Sanofi; Taiho Pharmaceutical
Research Funding - Lilly; Pfizer
 
Hironobu Ohmatsu
No Relationships to Disclose
 
Keiju Aokage
No Relationships to Disclose
 
Tomoyuki Hishida
No Relationships to Disclose
 
Junji Yoshida
Consulting or Advisory Role - Covidien; Johnson & Johnson
Research Funding - Konica Minolta (Inst)
 
Kanji Nagai
No Relationships to Disclose
 
Koichi Goto
Honoraria - AstraZeneca; Chugai Pharma; Kyowa Hakko Kirin; Lilly; Nippon Boehringer Ingelheim; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Yakult Pharmaceutical
Consulting or Advisory Role - Chugai Pharma; GlaxoSmithKline
Research Funding - AstraZeneca (Inst); Bayer (Inst); Chugai Pharma (Inst); GlaxoSmithKline (Inst); MSD (Inst); Nippon Boehringer Ingelheim (Inst); Ono Pharmaceutical (Inst); OxOnc (Inst); Quintiles (Inst); Taiho Pharmaceutical (Inst)
 
Masahiro Tsuboi
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Covidien; CSL Behring; Daiichi Sankyo; GlaxoSmithKline; Johnson & Johnson; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical; Teijin Pharma
 
Katsuya Tsuchihara
Honoraria - Chugai Pharma; Fujifilm; Integrated DNA Technologies; Taiho Pharmaceutical; Takeda